ABSTRACT
Hepatocellular carcinoma (HCC) is one of the major cancers with high mortality rate. Traditional drugs used in clinic are usually limited by the drug resistance and side effect and novel agents are still needed. Macrolide brefeldin A (BFA) is a well-known lead compound in cancer chemotherapy, however, with poor solubility and instability. In this study, to overcome these disadvantages, BFA was encapsulated in mixed nanomicelles based on TPGS and F127 copolymers (M-BFA). M-BFA was conferred high solubility, colloidal stability, and capability of sustained release of intact BFA. In vitro, M-BFA markedly inhibited the proliferation, induced G0/G1 phase arrest, and caspase-dependent apoptosis in human liver carcinoma HepG2 cells. Moreover, M-BFA also induced autophagic cell death via Akt/mTOR and ERK pathways. In HepG2 tumor-bearing xenograft mice, indocyanine green (ICG) as a fluorescent probe loaded in M-BFA distributed to the tumor tissue rapidly, prolonged the blood circulation, and improved the tumor accumulation capacity. More importantly, M-BFA (10 mg/kg) dramatically delayed the tumor progression and induced extensive necrosis of the tumor tissues. Taken together, the present work suggests that M-BFA has promising potential in HCC therapy.
Subject(s)
Antineoplastic Agents/administration & dosage , Brefeldin A/administration & dosage , Carcinoma, Hepatocellular/drug therapy , Liver Neoplasms/drug therapy , Micelles , Nanostructures/administration & dosage , Animals , Antineoplastic Agents/blood , Antineoplastic Agents/pharmacokinetics , Apoptosis/drug effects , Brefeldin A/blood , Brefeldin A/chemistry , Brefeldin A/pharmacokinetics , Carcinoma, Hepatocellular/metabolism , Carcinoma, Hepatocellular/pathology , Cell Line , Cell Survival/drug effects , Female , Humans , Liver Neoplasms/metabolism , Liver Neoplasms/pathology , Mice, Inbred BALB C , Nanostructures/chemistry , Polyethylenes/administration & dosage , Polyethylenes/chemistry , Polypropylenes/administration & dosage , Polypropylenes/chemistry , Rats, Sprague-Dawley , Tissue Distribution , Vitamin E/administration & dosage , Vitamin E/chemistryABSTRACT
BACKGROUND: In the ultrahigh molecular weight polyethylene (UHMWPE) prosthetic environment, fibroblasts affected by wear particles have the capacity of osteogenesis to reduce osteolysis. We aimed to assess the effects of macrophages on the osteogenic capability of fibroblasts treated with UHMWPE wear particles. METHODS: The effect of different concentrations of UHMWPE (0, 0.01, 0.1, and 1 mg/ml, respectively) on macrophage proliferation were validated by MTT assay to determine the optimum one. The fibroblasts viability was further determined in the co-culture system of UHMWPE particles and macrophage supernatants. The experiment was designed as seven groups: (A) fibroblasts only; (B) fibroblasts + 1 mg/ml UHMWPE particles; and (C1-C5) fibroblasts + 1/16, 1/8, 1/4, 1/2, and 1/1 supernatants of macrophage cultures stimulated by 1 mg/ml UHMWPE particles vs. fibroblast complete media, respectively. Alizarin red staining was used to detect calcium accumulation. The expression levels of osteogenic proteins were detected by Western blot and ELISA, including alkaline phosphatase (ALP) and osteocalcin (OCN). RESULTS: The concentration of 0.1 mg/ml was considered as the optimum concentration for macrophage proliferation due to the survival rate and was highest among the four concentrations. Fibroblast viability was better in the group of fibroblasts + 1/16 ratio of macrophage supernatants stimulated by 1 mg/ml of UHMWPE particles than the other groups (1:8, 1:4, 1:2, 1:1). ALP and OCN expressions were significantly decreased in the group of fibroblasts + 1/4, 1/2, and 1/1 supernatants stimulated by 1 mg/ml of UHMWPE particles compared with other groups (1/8, 1/16) and the group of fibroblasts + 1 mg/ml UHMWPE (p < 0.5). CONCLUSIONS: Macrophages are potentially involved in the periprosthetic osteolysis by reducing the osteogenic capability of fibroblasts treated with wear particles generated from UHMWPE materials in total hip arthroplasty.
Subject(s)
Macrophages/drug effects , Osteogenesis/drug effects , Particle Size , Polyethylenes/toxicity , Animals , Cell Line , Cell Proliferation/drug effects , Cell Proliferation/physiology , Dose-Response Relationship, Drug , Fibroblasts/drug effects , Fibroblasts/pathology , Fibroblasts/physiology , Humans , Macrophages/pathology , Macrophages/physiology , Mice , Osteogenesis/physiology , Polyethylenes/administration & dosageABSTRACT
OBJECTIVE: The Medpor porous polyethylene implant is reported to be safe and effective for sellar reconstruction after transsphenoidal surgery (TSS). However, we have observed several cases of delayed chronic sphenoid sinusitis related to the implant. The purpose of this study is to describe the presentation and management of implant-related sphenoid sinusitis after sellar reconstruction. METHODS: This is a retrospective study of patients who underwent endonasal TSS with Medpor sellar reconstruction between December 2008 and January 2013 at a tertiary care institution. Patient demographics, initial surgical management, sinonasal symptoms, postoperative imaging, sinusitis management, and resulting outcomes were analyzed. RESULTS: From 2008-2013, 139 patients underwent sellar reconstruction using Medpor. Five patients (3.6%) presented between 8 and 60 months after surgery with chronic sphenoid sinusitis that required surgical management. All 5 patients presented as outpatients for management of headaches and nasal drainage, 4 patients experienced chronic nasal congestion, and 3 patients noted recurrent sinusitis. At the time of revision surgery, all 5 patients were found to have mucosal inflammation and edema surrounding the implant, and 4 of the 5 had an exposed or partially extruded implant that was removed. CONCLUSIONS: Reconstruction of the sellar floor may be performed after TSS to prevent postoperative complications. Although porous polyethylene implants have previously been described as safe and effective for this purpose, surgeons should be aware of the risk of subsequent implant extrusion and chronic sphenoid sinusitis that can occur in a delayed manner.
Subject(s)
Adenoma/surgery , Biocompatible Materials/adverse effects , Pituitary Neoplasms/surgery , Polyethylenes/administration & dosage , Prostheses and Implants/adverse effects , Sella Turcica/surgery , Sphenoid Sinusitis/etiology , Adult , Aged , Aged, 80 and over , Chronic Disease , Endoscopy/methods , Female , Humans , Male , Middle Aged , Postoperative Complications/etiology , Retrospective Studies , Tertiary Care Centers , Tomography, X-Ray Computed , Treatment Outcome , Young AdultABSTRACT
The aim of this work was to prepare and evaluate cyclodextrins-modified poly(anhydride) nanoparticles to enhance the oral administration of glibenclamide. A conjugate polymer was synthesized by incorporating hydroxypropyl-ß-cyclodextrin to the backbone of poly(methylvinyl ether-co-maleic anhydride) via Steglich reaction. The degree of substitution of anhydride rings by cyclodextrins molecules was calculated to be 4.9% using H-NMR spectroscopy. A central composite design of experiments was used to optimize the preparative process. Under the optimal conditions, nanoparticles displayed a size of about 170â¯nm, a surface charge of -47â¯mV and a drug loading of 69⯵gâ¯GB/mg. X-ray diffraction studies confirmed the loss of the crystalline structure of GB due to its dispersion into the nanoparticles, either included into cyclodextrin cavities or entrapped in the polymer chains. Glibenclamide was mainly release by Fickian-diffusion in simulated intestinal fluid. GB-loaded nanoparticles produced a hypolipidemic effect over C. elegans N2 wild-type and daf-2 mutant. The action mechanism included daf-2 and daf-28 genes, both implicated in the insulin signaling pathway of C. elegans. In summary, the covalent linkage of cyclodextrin to the poly(anhydride) backbone could be an interesting strategy to prepare nanoparticles for the oral administration of glibenclamide.
Subject(s)
2-Hydroxypropyl-beta-cyclodextrin/administration & dosage , Caenorhabditis elegans/drug effects , Drug Carriers/administration & dosage , Glyburide/administration & dosage , Hypoglycemic Agents/administration & dosage , Maleates/administration & dosage , Nanoparticles/administration & dosage , Polyethylenes/administration & dosage , 2-Hydroxypropyl-beta-cyclodextrin/chemistry , Administration, Oral , Animals , Caenorhabditis elegans/metabolism , Drug Carriers/chemistry , Drug Liberation , Glyburide/chemistry , Hypoglycemic Agents/chemistry , Lipid Metabolism/drug effects , Maleates/chemistry , Nanoparticles/chemistry , Polyethylenes/chemistryABSTRACT
Raloxifene HCl (RH) has poor water solubility and due to its extensive first pass metabolism; its bioavailability is only 2%. The purpose of the present study was to enhance the aqueous solubility, oral bioavailability and anti-osteoporotic effects of RH by electro-sprayed nanoparticles (NPs) in ovariectomized rats. NPs containing RH and different ratio of poly(methyl vinyl ether-co-maleic acid) (PMVEMA) were electrosprayed. The voltage, distance of needle to the collector, flow rate of the solution and polymeric percentage were optimized according to the size of NPs and drug solubility. The optimized formulation was characterized by SEM, XRD, DSC, and FTIR. The pharmacokinetic parameters were studies by oral administration of a single dose of 15mg/kg in Wistar rats. The anti-osteoporotic effects were studied in female ovariectomized rats. Animals were treated with 6mg/kg/day for 2months then serum calcium, phosphorous and alkaline phosphatase levels were measured. RH loaded electrosprayed NPs showed 10-fold enhanced solubility compared to the free drug. Moreover, the XRD and SEM tests displayed an amorphous state of drug in the NPs. FTIR and DSC tests revealed no interaction between the polymer and the drug. Serum calcium, phosphorous and alkaline phosphatase levels were significantly decreased in ovariectomized rats receiving oral RH NPs (P<0.05). No significant difference was detected between RH NPs and estradiol groups (P>0.05). Oral bioavailability of NPs showed 7.5-fold increase compared to the pure drug. The electrosprayed PMVEMA nanoparticles can enhance solubility, bioavailability and antiosteoporotic effects of RH.
Subject(s)
Bone Density Conservation Agents/administration & dosage , Maleates/administration & dosage , Nanoparticles/administration & dosage , Osteoporosis/drug therapy , Polyethylenes/administration & dosage , Raloxifene Hydrochloride/administration & dosage , Administration, Oral , Alkaline Phosphatase/blood , Animals , Biological Availability , Bone Density Conservation Agents/blood , Bone Density Conservation Agents/chemistry , Bone Density Conservation Agents/pharmacokinetics , Calcium/blood , Female , Maleates/chemistry , Maleates/pharmacokinetics , Microscopy, Electron, Scanning , Nanoparticles/chemistry , Nanoparticles/ultrastructure , Osteoporosis/blood , Ovariectomy , Phosphorus/blood , Polyethylenes/chemistry , Polyethylenes/pharmacokinetics , Raloxifene Hydrochloride/blood , Raloxifene Hydrochloride/chemistry , Raloxifene Hydrochloride/pharmacokinetics , Rats, Wistar , Solubility , Technology, PharmaceuticalABSTRACT
INTRODUCTION: We describe our experience of cranioplasty after a calvarial defect, following an external decompressive craniectomy, with the Medpor® (Stryker®) porous polyethylene implant for cosmetic cranioplasty and reconstruction. METHODS: A retrospective chart review was performed on 23 consecutive patients who underwent cranioplasty at a single institution between January 2013 and January 2016: 9 patients after head injury and 14 patients after vascular event (ruptured aneurysm, intraprenchymal haematoma, malignant cerebrovascular accident). All patients with cranioplasties after oncological resection or infection were excluded. These cranioplasties were performed using porous polyethylene sheet (Medpor®) and contoured with a burr or scissors in the sterile field, and fixed to the calvarial bone with screws. RESULTS: Porous polyethylene sheet (Medpor®) is a proven material used for cranial reconstruction in neurosurgery and maxillofacial surgery with a biocompatibility advantage. The implant can be directly used in an emergency context. The average operating time was 72minutes. An average delay of 527 days (1 year and 5months) with a median of 985 days (43; 4206) occurred between craniectomy and the cranioplasty. There was only one set back implant due to scalp necrosis with infection for a recovery-unit patient. CONCLUSION: Porous polyethylene is an excellent restorative material for the reconstruction of large sized cranial defects and can be also used safely in reconstruction of the cranium. The cosmetic results are good, easy to perform, with a low complication rate.
Subject(s)
Biocompatible Materials/administration & dosage , Cerebrovascular Disorders/surgery , Craniocerebral Trauma/surgery , Plastic Surgery Procedures/methods , Polyethylenes/administration & dosage , Adult , Aged , Decompressive Craniectomy , Female , Humans , Male , Middle Aged , Prostheses and Implants , Retrospective Studies , Skull/surgery , Surgical Wound/surgery , Young AdultABSTRACT
Particle-induced osteolysis, which by definition is an aseptic inflammatory reaction to implant-derived wear debris eventually leading to local bone destruction, remains the major reason for long-term failure of orthopedic endoprostheses. Fetuin-A, a 66kDa glycoprotein with diverse functions, is found to be enriched in bone. Besides being an important inhibitor of ectopic calcification, it has been described to influence the production of mediators of inflammation. Furthermore, a regulatory role in bone metabolism has been assigned. In the present study, the influence of a single dose of bovine fetuin-A, intraperitoneally injected in mice subjected to particle-induced osteolysis of the calvaria, was analyzed. Twenty-eight male C57BL/6 mice, twelve weeks of age, were randomly divided into four groups. Groups 2 and 4 were subjected to ultra-high molecular weight polyethylene (UHMWPE) particles placed on their calvariae while groups 1 and 3 were sham-operated. Furthermore, groups 3 and 4 received a single intraperitoneal injection of 20mg bovine fetuin-A while groups 1 and 2 were treated with physiologic saline. After 14days calvarial bone was qualitatively and quantitatively assessed using microcomputed tomography (µCT) and histomorphometrical approaches. Application of fetuin-A led to a reduction of particle-induced osteolysis in terms of visible osteolytic lesions and eroded bone surface. The reduction of bone thickness and bone volume, as elicited by UHMWPE, was alleviated by fetuin-A. In conclusion, fetuin-A was found to exert an anti-resorptive effect on particle-induced osteolysis in-vivo. Thus, fetuin-A could play a potentially osteoprotective role in the treatment of bone metabolic disorders.
Subject(s)
Bone Resorption/complications , Bone Resorption/drug therapy , Osteolysis/complications , Osteolysis/drug therapy , Polyethylenes/administration & dosage , Skull/pathology , alpha-2-HS-Glycoprotein/administration & dosage , alpha-2-HS-Glycoprotein/therapeutic use , Animals , Bone Resorption/pathology , Bone and Bones/drug effects , Bone and Bones/pathology , Cattle , Cell Count , Imaging, Three-Dimensional , Injections, Intraperitoneal , Mice , Mice, Inbred C57BL , Organ Size , Osteoclasts/drug effects , Osteoclasts/pathology , Osteolysis/pathology , alpha-2-HS-Glycoprotein/pharmacologyABSTRACT
Particle-induced osteolysis and periprosthetic joint infection (PJI) are closely associated with periprosthetic tissue immune function. The objective of this study was to determine the effects of polyethylene particles on inflammation and response against S. aureus. Effects that vitamin E-diffused cross-linked UHMWPE (VE-PE) particles had on apoptosis, inflammation, and bactericidal activities compared to virgin cross-linked UHMWPE (control PE) particles were examined. Murine RAW 264.7 macrophages exposed to VE-PE particles in vitro were less apoptotic, secreted less tumor necrosis factor (TNF)-α, and responded more effectively against lipopolysaccharide or S. aureus compared to control PE particles. Implantation of VE-PE particles in murine calvaria in vivo caused less reactive oxygen species generation, less apoptosis, and less osteolysis compared to control PE particles. Implantation of PE particles in mice calvaria for 28 days, followed by inoculation with S. aureus in the same site where PE particles were implanted, demonstrated enhanced S. aureus clearance in the VE-PE group at day 33 after inoculation. These findings indicate that VE-PE particles might be less inflammatory and might preserve innate immunity of local tissue, allowing for enhanced clearance of bacteria.
Subject(s)
Anti-Bacterial Agents/pharmacology , Immunity, Innate/drug effects , Polyethylenes/pharmacology , Prostheses and Implants/adverse effects , Staphylococcal Infections/prevention & control , Staphylococcus aureus/drug effects , Vitamin E/pharmacology , Animals , Anti-Bacterial Agents/administration & dosage , Anti-Bacterial Agents/adverse effects , Apoptosis/drug effects , Inflammation/chemically induced , Inflammation/immunology , Macrophages/drug effects , Macrophages/immunology , Macrophages/microbiology , Male , Mice , Mice, Inbred C57BL , Osteolysis/chemically induced , Osteolysis/immunology , Polyethylenes/administration & dosage , Polyethylenes/adverse effects , RAW 264.7 Cells , Staphylococcal Infections/immunology , Staphylococcus aureus/immunology , Vitamin E/administration & dosage , Vitamin E/adverse effectsABSTRACT
Cross-linking of natural and synthetic polymers is widely explored to achieve the desired material properties (mechanical strength, drug loading capacity, swelling and erosion rates). However, the potential of polymers produced by crosslinking poly (methyl vinyl ether-co-maleic acid) (PMVE/MA) and pectin (PE) in pharmaceutics is mainly unexplored so far. We have investigated the effect of various esterification conditions and pectin content on the physicochemical properties. Materials have been characterized by fourier transform infrared, differential scanning calorimetry and scanning electron microscopy. In addition, swelling and bioadhesive features of PMVE/MA-PE hydrogel systems were investigated. A band shift for the carbonyl group from 1706 to 1776cm-1, and glass transition (Tg) increased from 55.4±0.9°C to 119.5±0.3°C confirmed the formation of esterification reaction within the cross-linked films. Cross-linked PMVE/MA:PE films with a ratio of 5 demonstrated a superior mass increase when compared to 2.5, 3.125, 3.75, 6.25, and 7.5 ratios of the same hydrogel film. Formulations containing PMVE/MA and pectin with a ratio of 3.75 showed superior bioadhesive features. For the first time, we engineered three-dimensional printing based swell-able microneedle arrays made out of cross-linked PMVE/MA-PE. Microneedle arrays height and aspect ratio were ranged from 702.5±11.9µm to 726±23.3µm and 3.12±0.20 to 3.29±0.21, respectively. Cross-linked PMVE/MA-PE Microneedle arrays (10-2, 24h) indicated the least height loss, 22.33±4.15%, during axial compression test; whilst, transverse failure of cross-linked PMVE/MA-PE Microneedle arrays was varied from 0.15±0.05 to 0.25±0.04N/needle. In conclusion, we obtained a novel cross-linked polymer system with promising features of drug delivery and bio-analytical applications.
Subject(s)
Drug Delivery Systems/methods , Maleates/chemical synthesis , Needles , Pectins/chemical synthesis , Polyethylenes/chemical synthesis , Printing, Three-Dimensional , Skin Absorption/physiology , Animals , Chickens , Cross-Linking Reagents/administration & dosage , Cross-Linking Reagents/chemical synthesis , Cross-Linking Reagents/metabolism , Delayed-Action Preparations/administration & dosage , Delayed-Action Preparations/chemical synthesis , Delayed-Action Preparations/metabolism , Gels , Hydrogel, Polyethylene Glycol Dimethacrylate , Maleates/administration & dosage , Maleates/metabolism , Pectins/administration & dosage , Pectins/metabolism , Polyethylenes/administration & dosage , Polyethylenes/metabolism , Skin Absorption/drug effectsABSTRACT
Metastasis impedes the successful chemotherapy for breast cancer. In this study, an Akt inhibitor (quercetin, Qu) was co-delivered with a chemotherapeutic agent (docetaxel, DTX) by using hyaluronic acid (HA)-modified nanoparticles (NPs) as vectors to block metastasis. Dual DTX/Qu-loaded HA/polylactic-co-glycolic acid-polyethyleneimine NPs (PP-HA/NPs) were prepared through a modified emulsion solvent evaporation technique. The particle size of PP-HA/NPs with narrow polydispersity was 209.8±10.8nm. Wound healing assay revealed that Qu co-delivery and HA modification elicited synergistic inhibitory effects on cell motility. The downregulation of p-Akt and matrix metalloproteinase-9 (MMP-9) expression contributed to the significant inhibition of cell migration and invasion with inhibition rates of 95.6% and 99.3%, respectively. Further studies indicated that PP-HA/NPs could be efficiently uptaken by 4T1 breast cancer cells and could further induce cytotoxicity, decrease colony formation and promote cell apoptosis. Biodistribution assay demonstrated PP-HA/NPs also enhanced drug accumulation in the tumor and lungs and predicted that PP-HA/NPs could be employed as an effective therapy for primary tumor and pulmonary metastasis. Therefore, PP-HA/NPs could be a promising delivery system to treat metastatic breast cancer effectively.
Subject(s)
Antineoplastic Agents/administration & dosage , Antioxidants/administration & dosage , Matrix Metalloproteinase Inhibitors/administration & dosage , Nanoparticles/administration & dosage , Quercetin/administration & dosage , Taxoids/administration & dosage , Animals , Antineoplastic Agents/chemistry , Antineoplastic Agents/pharmacokinetics , Antioxidants/chemistry , Antioxidants/pharmacokinetics , Apoptosis/drug effects , Breast Neoplasms , Cell Line, Tumor , Cell Movement/drug effects , Cell Survival/drug effects , Docetaxel , Female , Hyaluronic Acid/administration & dosage , Hyaluronic Acid/chemistry , Hyaluronic Acid/pharmacokinetics , Imines/administration & dosage , Imines/chemistry , Imines/pharmacokinetics , Lactic Acid/administration & dosage , Lactic Acid/chemistry , Lactic Acid/pharmacokinetics , Matrix Metalloproteinase 9/metabolism , Matrix Metalloproteinase Inhibitors/chemistry , Matrix Metalloproteinase Inhibitors/pharmacokinetics , Mice, Inbred BALB C , Nanoparticles/chemistry , Polyethylenes/administration & dosage , Polyethylenes/chemistry , Polyethylenes/pharmacokinetics , Polyglycolic Acid/administration & dosage , Polyglycolic Acid/chemistry , Polyglycolic Acid/pharmacokinetics , Polylactic Acid-Polyglycolic Acid Copolymer , Proto-Oncogene Proteins c-akt/antagonists & inhibitors , Proto-Oncogene Proteins c-akt/metabolism , Quercetin/chemistry , Quercetin/pharmacokinetics , Taxoids/chemistry , Taxoids/pharmacokinetics , Wound Healing/drug effectsABSTRACT
This study systematically determined the optimal dosage ratio and the viscosity (η) of co-coagulants, polyaluminum chloride (PAC) and poly dimethyldiallylammonium chloride (PDMDAAC), on coagulation performance and membrane fouling in a hybrid coagulation-ultrafiltration (C-UF) process for natural organic matter (NOM) removal. Floc characteristics-including floc size, fractal dimension, strength and re-growth ability-were studied with respect to coagulant-dosing operations. Membrane fouling was evaluated in association with assessment of NOM removal performance by the hybrid process. The best coagulation performance was achieved when PAC and PDMDAAC were dosed with 1.0 mg/L and 0.1 mg/L, respectively. The addition of PDMDAAC could enhance the NOM removal efficiency, especially at low PAC dosages. Co-coagulants PAC/PDMDAAC (ηPDMDAAC = 2.18 dL/g) resulted in formation of the largest flocs with the smallest Df under all shear conditions, while the flocs formed by PAC/PDMDAAC (ηPDMDAAC = 1.86 dL/g) had higher recovery abilities. The results from ultrafiltration experiments indicated that coagulation using PAC/PDMDAAC with a viscosity range from 0.99 dL/g to 1.86 dL/g can significantly reduce membrane fouling, leading to increasing water fluxes from 0.1170 to 0.4906 in the ultrafiltration process.
Subject(s)
Aluminum Hydroxide/chemistry , Equipment Contamination/prevention & control , Membranes, Artificial , Polyethylenes/chemistry , Quaternary Ammonium Compounds/chemistry , Ultrafiltration/instrumentation , Water Purification/instrumentation , Aluminum Hydroxide/administration & dosage , Flocculation , Humic Substances/analysis , Polyethylenes/administration & dosage , Quaternary Ammonium Compounds/administration & dosage , Viscosity , Water Purification/methodsABSTRACT
Cervical cancer is the fourth most common cancer in women worldwide, and existing treatments cause severe side effects and great burdens. Thus, the development of safe, inexpensive therapeutic agents is necessary. Curcumin (Cur), a well-known natural product, exerts promising anti-cancer activities against various cancer types. However, its therapeutic efficacy is severely restrained due to rapid degradation, poor aqueous solubility, and low bioavailability. The objective of this study was to investigate the therapeutic potential of novel curcumin-loaded TPGS/F127/P123 mixed polymeric micelles (Cur@NPT100) for cervical cancer treatment. The Cur@NPT100 exhibited an average size of approximately 19 nm, a zeta potential of around -4 mV, a drug loading of 8.18 ± 0.36%, and an encapsulation efficiency of 79.38 ± 4.65%. Unlike free Cur, Cur@NPT100 are readily dispersed in aqueous medium, showing enhanced stability and a sustained release profile over a 6-day period. In vitro cell culture experiments revealed that TPGS/F127/P123 mixed polymeric micelles (NPT100) based nanocarriers substantially promoted the selective cellular uptake of Cur into HeLa cells rather than by non-cancerous NIH3T3 cells, inducing higher cytotoxicity and greater apoptosis and significantly increasing the percentage of cells arrested at the G2/M phase of the cell cycle. Additionally, the Cur@NPT100 facilitated more Cur accumulation in the mitochondria and decreased the mitochondrial membrane potential. In addition, western blot assays demonstrated that Cur@NPT100 were more potent than free Cur at activating the mitochondria-mediated apoptosis pathway. In vivo results further confirmed that Cur@NPT100 exhibited a much higher antitumor efficacy than free Cur and had excellent biocompatibility. In conclusion, Cur@NPT100 might be an effective therapeutic agent for cervical cancer.
Subject(s)
Antineoplastic Agents/administration & dosage , Curcumin , Micelles , Uterine Cervical Neoplasms/drug therapy , Vitamin E/administration & dosage , Animals , Cell Line, Tumor , Drug Carriers , Female , HeLa Cells , Humans , Materials Testing , Mice , NIH 3T3 Cells , Polyethylenes/administration & dosage , Polypropylenes/administration & dosageABSTRACT
Aseptic loosening mediated by wear particle-induced osteolysis (PIO) remains the major cause of implant loosening in endoprosthetic surgery. The development of new vitamin E (α-tocopherol)-blended ultra-high molecular weight polyethylene (VE-UHMWPE) with increased oxidation resistance and improved mechanical properties has raised hopes. Furthermore, regenerative approaches may be opened, as vitamin E supplementation has shown neuroprotective characteristics mediated via calcitonin gene-related peptide (CGRP), which is known to affect bone remodeling in PIO. Therefore, the present study aimed to further clarify the impact of VE-UHMWPE wear particles on the osseous microenvironment and to identify the potential modulatory pathways involved. Using an established murine calvaria model, mice were subjected to sham operation (SHAM group), or treated with UHMWPE or VE-UHMWPE particles for different experimental durations (7, 14 and 28 days; n=6/group). Morphometric analysis by micro-computed tomography detected significant (p<0.01) and comparable signs of PIO in all particle-treated groups, whereas markers of inflammation [tumor necrosis factor (TNF)-α/tartrate resistant acid phosphatase (TRAP) staining] and bone remodeling [Dickkopf-related protein 1 (DKK-1)/osteoprotegerin (OPG)] were most affected in the early stages following surgery. Taking the present data into account, VE-UHMWPE appears to have a promising biocompatibility and increased ageing resistance. According to the α-CGRP serum levels and immunohistochemistry, the impact of vitamin E on neuropeptidergic signaling and its chance for regenerative approaches requires further investigation.
Subject(s)
Osteolysis/etiology , Osteolysis/pathology , Polyethylenes , Vitamin E , Animals , Biomarkers , Bone Resorption/metabolism , Bone Resorption/pathology , Bone and Bones/metabolism , Bone and Bones/pathology , Calcitonin Gene-Related Peptide/metabolism , Granuloma/metabolism , Granuloma/pathology , Inflammation/etiology , Inflammation/metabolism , Inflammation/pathology , Male , Mice , Osteoclasts/metabolism , Osteogenesis , Osteolysis/diagnostic imaging , Osteolysis/metabolism , Polyethylenes/administration & dosage , Skull/diagnostic imaging , Skull/metabolism , Skull/pathology , Vitamin E/administration & dosage , X-Ray MicrotomographyABSTRACT
Current biomaterials for auricular replacement are associated with high rates of infection and extrusion. The development of new auricular biomaterials that mimic the mechanical properties of native tissue and promote desirable cellular interactions may prevent implant failure. A porous 3D nanocomposite scaffold (NS) based on POSS-PCU (polyhedral oligomeric silsesquioxane nanocage into polycarbonate based urea-urethane) is developed with an elastic modulus similar to native ear. In vitro biological interactions on this NS reveal greater protein adsorption, increased fibroblast adhesion, proliferation, and collagen production compared with Medpor (the current synthetic auricular implant). In vivo, the POSS-PCU with larger pores (NS2; 150-250 µm) have greater tissue ingrowth (≈5.8× and ≈1.4 × increase) than the POSS-PCU with smaller pores (NS1; 100-50 µm) and when compared to Medpor (>100 µm). The NS2 with the larger pores demonstrates a reduced fibrotic encapsulation compared with NS1 and Medpor (≈4.1× and ≈1.6×, respectively; P < 0.05). Porosity also influences the amount of neovascularization within the implants, with no blood vessel observed in NS1 (12 weeks postimplantation). The lack of chronic inflammatory response for all materials may indicate that the elastic modulus and pore size of the implant scaffold could be important design considerations for influencing fibrotic responses to auricular and other soft tissue implants.
Subject(s)
Biocompatible Materials/administration & dosage , Ear Cartilage/drug effects , Nanocomposites/administration & dosage , Animals , Biocompatible Materials/chemistry , Cell Adhesion/drug effects , Cell Proliferation/drug effects , Collagen/metabolism , Elastic Modulus/drug effects , Fibroblasts/drug effects , Male , Materials Testing/methods , Nanocomposites/chemistry , Organosilicon Compounds/administration & dosage , Organosilicon Compounds/chemistry , Polycarboxylate Cement/chemistry , Polyethylenes/administration & dosage , Polyethylenes/chemistry , Polymers/administration & dosage , Polymers/chemistry , Polyurethanes/administration & dosage , Polyurethanes/chemistry , Porosity , Prostheses and Implants , Rats , Rats, Sprague-Dawley , Surface PropertiesABSTRACT
Selol is a semi-synthetic compound containing selenite that is effective against cancerous cells and safer for clinical applications in comparison with other inorganic forms of selenite. Recently, we have developed a formulation of poly(methyl vinyl ether-co-maleic anhydride)-shelled selol nanocapsules (SPN), which reduced the proliferative activity of lung adenocarcinoma cells and presented little deleterious effects on normal cells in in vitro studies. In this study, we report on the antitumor activity and systemic effects induced by this formulation in chemically induced lung adenocarcinoma-bearing mice. The in vivo antitumor activity of the SPN was verified by macroscopic quantification, immunohistochemistry and morphological analyses. Toxicity analyses were performed by evaluations of the kidney, liver, and spleen; analyses of hemogram and plasma levels of alanine aminotransferase, aspartate transaminase, urea, and creatinine; and DNA fragmentation and cell cycle activity of the bone marrow cells. Furthermore, we investigated the potential of the SPN formulation to cause hemolysis, activate the complement system, provoke an inflammatory response and change the conformation of the plasma proteins. Our results showed that the SPN reduced the area of the surface tumor nodules but not the total number of tumor nodules. The biochemical and hematological findings were suggestive of the low systemic toxicity of the SPN formulation. The surface properties of the selol nanocapsules point to characteristics that are consistent with the treatment of the tumors in vivo: low hemolytic activity, weak inflammatory reaction with no activation of the complement system, and mild or absent conformational changes of the plasma proteins. In conclusion, this report suggests that the SPN formulation investigated herein exhibits anti-tumoral effects against lung adenocarcinoma in vivo and is associated with low systemic toxicity and high biocompatibility.
Subject(s)
Adenocarcinoma/drug therapy , Antineoplastic Agents/administration & dosage , Lung Neoplasms/drug therapy , Maleates/administration & dosage , Nanocapsules/administration & dosage , Polyethylenes/administration & dosage , Selenium Compounds/administration & dosage , Adenocarcinoma/ultrastructure , Adenocarcinoma of Lung , Animals , Antineoplastic Agents/chemistry , Antineoplastic Agents/toxicity , Body Weight/drug effects , Cell Line, Tumor , Cell Proliferation/drug effects , Complement System Proteins/metabolism , DNA Fragmentation/drug effects , Female , Inflammation/chemically induced , Lung Neoplasms/ultrastructure , Maleates/chemistry , Maleates/toxicity , Mice , Nanocapsules/chemistry , Nanocapsules/toxicity , Organ Size/drug effects , Polyethylenes/chemistry , Polyethylenes/toxicity , Selenium Compounds/chemistry , Selenium Compounds/toxicityABSTRACT
Integrin-targeted nanoparticles are promising for the delivery of small interfering RNA (siRNA) to tumor cells or tumor endothelium in cancer therapy aiming at silencing genes essential for tumor growth. However, during the process of optimizing and realizing their full potential, it is pertinent to gain a basic mechanistic understanding of the bottlenecks existing for nanoparticle-mediated intracellular delivery. We designed αvß3 integrin-targeted nanoparticles by coupling arginine-glycine-aspartate (RGD) or RGD peptidomimetic (RGDp) ligands to the surface of poly(ethylene glycol) (PEG) grafted chitosan-poly(ethylene imine) hybrid nanoparticles. The amount of intracellular siRNA delivered by αvß3-targeted versus non-targeted nanoparticles was quantified in the human non-small cell lung carcinoma cell line H1299 expressing enhanced green fluorescent protein (EGFP) using a stem-loop reverse transcription quantitative polymerase chain reaction (RT-qPCR) approach. Data demonstrated that the internalization of αvß3-targeted nanoparticles was highly dependent on the surface concentration of the ligand. Above a certain threshold concentration, the use of targeted nanoparticles provided a two-fold increase in the number of siRNA copies/cell, subsequently resulting in as much as 90% silencing of EGFP at well-tolerated carrier concentrations. In contrast, non-targeted nanoparticles mediated low levels of gene silencing, despite relatively high intracellular siRNA concentrations, indicating that these nanoparticles might end up in late endosomes or lysosomes without releasing their cargo to the cell cytoplasm. Thus, the silencing efficiency of the chitosan-based nanoparticles is strongly dependent on the uptake and the intracellular trafficking in H1299 EGFP cells, which is critical information towards a more complete understanding of the delivery mechanism that can facilitate the future design of efficient siRNA delivery systems.
Subject(s)
Chitosan/administration & dosage , Imines/administration & dosage , Integrins/administration & dosage , Nanoparticles/administration & dosage , Polyethylene Glycols/administration & dosage , Polyethylenes/administration & dosage , RNA, Small Interfering/administration & dosage , Cell Line, Tumor , Gene Transfer Techniques , Green Fluorescent Proteins/biosynthesis , Humans , Integrins/genetics , Intracellular Fluid/drug effects , Intracellular Fluid/metabolism , RNA, Small Interfering/geneticsABSTRACT
The treatment of impaired wounds requires the use of biomaterials that can provide mechanical and biological queues to the surrounding environment to promote angiogenesis, granulation tissue formation, and wound closure. Porous hydrogels show promotion of angiogenesis, even in the absence of proangiogenic factors. It is hypothesized that the added delivery of nonviral DNA encoding for proangiogenic growth factors can further enhance this effect. Here, 100 and 60 µm porous and nonporous (n-pore) hyaluronic acid-MMP hydrogels with encapsulated reporter (pGFPluc) or proangiogenic (pVEGF) plasmids are used to investigate scaffold-mediated gene delivery for local gene therapy in a diabetic wound healing mouse model. Porous hydrogels allow for significantly faster wound closure compared with n-pore hydrogels, which do not degrade and essentially provide a mechanical barrier to closure. Interestingly, the delivery of pDNA/PEI polyplexes positively promotes granulation tissue formation even when the DNA does not encode for an angiogenic protein. And although transfected cells are present throughout the granulation tissue surrounding, all hydrogels at 2 weeks, pVEGF delivery does not further enhance the angiogenic response. Despite this, the presence of transfected cells shows promise for the use of polyplex-loaded porous hydrogels for local gene delivery in the treatment of diabetic wounds.
Subject(s)
DNA/administration & dosage , Diabetes Complications/drug therapy , Hyaluronic Acid/administration & dosage , Hydrogels/administration & dosage , Wound Healing/drug effects , Animals , Biocompatible Materials/administration & dosage , Diabetes Complications/genetics , Diabetes Mellitus, Experimental/complications , Diabetes Mellitus, Experimental/genetics , Disease Models, Animal , Female , Gene Transfer Techniques , Imines/administration & dosage , Mice , Plasmids/genetics , Polyethylenes/administration & dosage , Porosity , Transfection/methods , Vascular Endothelial Growth Factor A/metabolism , Wound Healing/geneticsABSTRACT
OBJECTIVE: Wound complications negatively affect outcomes of lower extremity arterial reconstruction. By way of an investigator initiated clinical trial, we tested the hypothesis that a silver-eluting alginate topical surgical dressing would lower wound complication rates in patients undergoing open arterial procedures in the lower extremity. METHODS: The study block-randomized 500 patients at three institutions to standard gauze or silver alginate dressings placed over incisions after leg arterial surgery. This original operating room dressing remained until gross soiling, clinical need to remove, or postoperative day 3, whichever was first. Subsequent care was at the provider's discretion. The primary end point was 30-day wound complication incidence generally based on National Surgical Quality Improvement Program guidelines. Demographic, clinical, quality of life, and economic end points were also collected. Wound closure was at the surgeon's discretion. RESULTS: Participants (72% male) were 84% white, 45% were diabetic, 41% had critical limb ischemia, and 32% had claudication (with aneurysm, bypass revision, other). The overall 30-day wound complication incidence was 30%, with superficial surgical site infection as the most common. In intent-to-treat analysis, silver alginate had no effect on wound complications. Multivariable analysis showed that Coumadin (Bristol-Myers Squibb, Princeton, NJ; odds ratio [OR], 1.72; 95% confidence interval [CI], 1.03-2.87; P = .03), higher body mass index (OR, 1.05; 95% CI, 1.01-1.09; P = .01), and the use of no conduit/material (OR, 0.12; 95% CI, 0.82-3.59; P < .001) were independently associated with wound complications. CONCLUSIONS: The incidence of wound complications remains high in contemporary open lower extremity arterial surgery. Under the study conditions, a silver-eluting alginate dressing showed no effect on the incidence of wound complications.
Subject(s)
Alginates/administration & dosage , Anti-Infective Agents, Local/administration & dosage , Bandages , Lower Extremity/blood supply , Peripheral Arterial Disease/surgery , Polyesters/administration & dosage , Polyethylenes/administration & dosage , Silver Compounds/administration & dosage , Vascular Surgical Procedures/adverse effects , Administration, Topical , Aged , Boston/epidemiology , Chi-Square Distribution , Female , Glucuronic Acid/administration & dosage , Hexuronic Acids/administration & dosage , Humans , Incidence , Intention to Treat Analysis , Logistic Models , Male , Middle Aged , Multivariate Analysis , Odds Ratio , Peripheral Arterial Disease/diagnosis , Prospective Studies , Surgical Wound Infection/epidemiology , Surgical Wound Infection/prevention & control , Texas/epidemiology , Time Factors , Treatment Outcome , Wound Healing/drug effectsSubject(s)
Alginates/administration & dosage , Anti-Infective Agents, Local/administration & dosage , Bandages , Lower Extremity/blood supply , Peripheral Arterial Disease/surgery , Polyesters/administration & dosage , Polyethylenes/administration & dosage , Silver Compounds/administration & dosage , Vascular Surgical Procedures/adverse effects , Female , Glucuronic Acid/administration & dosage , Hexuronic Acids/administration & dosage , Humans , MaleABSTRACT
Silver is used worldwide in dressings for wound management. Silver has demonstrated great efficacy against a broad range of microorganisms, but there is very little data about the systemic absorption and toxicity of silver in vivo. In this study, the antimicrobial effect of the silver-coated dressing (SilverCoat(®)) was evaluated in vitro against the most common microorganisms found in wounds, including Pseudomonas aeruginosa, Candida albicans, Staphylococcus aureus, Methicillin-resistant Staphylococcus aureus and Klebsiella pneumoniae. We also performed an excisional skin lesion assay in mice to evaluate wound healing after 14 days of treatment with a silver-coated dressing, and we measured the amount of silver in the blood, the kidneys and the liver after treatment. Our data demonstrated that the nylon threads coated with metallic silver have a satisfactory antimicrobial effect in vitro, and the prolonged use of these threads did not lead to systemic silver absorption, did not induce toxicity in the kidneys and the liver and were not detrimental to the normal wound-healing process.